Conditioned Medium Wharton's Jelly-derived mesenchymal stem cells therapy(Universitas Tarumanagara)

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameConditioned Medium Wharton's Jelly-derived mesenchymal stem cells therapy(Universitas Tarumanagara)
Drug Alias NameCM-WJMSCs(Universitas Tarumanagara)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsLeprosy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndonesia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversitas Tarumanagara
China Registration ClassN/A

Develop Information

Active CompaniesUniversitas Tarumanagara
Inactive CompaniesN/A
Active IndicationsLeprosy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A